×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.95 | -1.93 | NA | -7.86 | 0 | |
| Windlas Biotech Limited | 2376.24 | 149.54 | 2331.02 | 7.03 | 1,945 | 29.8 |
| Hester Biosciences Limited | 780.84 | 93.1 | 774.15 | 10.94 | 1635 | 43.5 |
| Tarsons Products Limited | 1,163.15 | 50.36 | 1,078.93 | 0.95 | 1635 | 59.4 |
Windlas Biotech Limited, with Security Code 543329, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 144.8 | 152.7 | 162.2 | 171.3 | 175.2 | 187.0 | 195.0 | 233.1 |
| Expenses | 127.6 | 134.0 | 141.9 | 149.4 | 154.3 | 164.0 | 170.4 | 208.7 |
| Operating Profit | 17.1 | 18.7 | 20.3 | 21.9 | 20.9 | 23.0 | 24.6 | 24.4 |
| OPM % | 11.84% | 12.24% | 12.54% | 12.81% | 11.92% | 12.33% | 12.63% | 10.46% |
| Other Income | 2.6 | 3.2 | 3.2 | 4.4 | 4.1 | 4.8 | 3.7 | 4.5 |
| Interest | 0.2 | 0.3 | 0.3 | 0.3 | 0.5 | 1.1 | 1.5 | 1.3 |
| Depreciation | 3.2 | 3.3 | 3.4 | 3.5 | 6.2 | 6.5 | 6.9 | 7.7 |
| Profit before tax | 16.3 | 18.3 | 19.8 | 22.6 | 18.3 | 20.3 | 20.0 | 19.9 |
| Tax % | -26.2% | -23.4% | -23.8% | 24.9% | 26.4% | 22.8% | -23.8% | 24.9% |
| Net Profit | 12.1 | 14.0 | 15.1 | 16.9 | 13.5 | 15.7 | 15.2 | 15.0 |
| EPS in Rs | 5.79 | 6.75 | 7.26 | 8.12 | 6.44 | 7.43 | 7.21 | 7.03 |
| Metrics | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 171.3 | 175.2 | 187.0 | 195.0 | 202.7 | 210.1 | 222.4 | 222.4 |
| Expenses | 149.3 | 154.3 | 164.0 | 170.4 | 177.1 | 183.6 | 193.8 | 193.8 |
| Operating Profit | 22.0 | 20.9 | 23.0 | 24.6 | 25.6 | 26.5 | 28.6 | 28.6 |
| OPM % | 12.85% | 11.92% | 12.33% | 12.63% | 12.61% | 12.63% | 12.84% | 12.84% |
| Other Income | 4.4 | 4.1 | 4.8 | 4.1 | 4.9 | 5.2 | 3.6 | 3.6 |
| Interest | 0.3 | 0.5 | 1.1 | 1.5 | 1.3 | 1.1 | 1.0 | 1.0 |
| Depreciation | 3.5 | 6.2 | 6.5 | 6.9 | 8.3 | 7.4 | 7.6 | 7.6 |
| Profit before tax | 22.6 | 18.3 | 20.3 | 20.3 | 20.8 | 23.3 | 23.6 | 23.6 |
| Tax % | -24.9% | -26.4% | -22.8% | 23.4% | -21.6% | 24% | 24.5% | -24.5% |
| Net Profit | 17.0 | 13.5 | 15.7 | 15.6 | 16.3 | 17.7 | 17.8 | 17.8 |
| EPS in Rs | 8.14 | 6.44 | 7.43 | 7.38 | 0 | 8.34 | 8.4 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 22% |
| 3 Years: | 16% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 63% |
| 1 Year: | 56% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 30% |
| 3 Years: | 17% |
| TTM: | 5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 63% |
| 1 Year: | 56% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|